Search results for " Contrast Agent"

showing 10 items of 21 documents

[Gadolinium-containing contrast agents: Gadoterat-meglumine is safe in patients with chronic renal failure].

2014

Objective To prospectively compare the renal safety of meglumine gadoterate (Gd-DOTA)-enhanced magnetic resonance imaging (MRI) to a control group (unenhanced MRI) in high-risk patients. Methods Patients with chronic kidney disease (CKD) scheduled for MRI procedures were screened. The primary endpoint was the percentage of patients with an elevation of serum creatinine levels, measured 72 ± 24 h after the MRI procedure, by at least 25 % or 44.2 μmol/l (0.5 mg/dl) from baseline. A non-inferiority margin of the between-group difference was set at −15 % for statistical analysis of the primary endpoint. Main secondary endpoints were the variation in serum creatinine and eGFR values between base…

MaleDrug-Related Side Effects and Adverse ReactionsContrast MediaAcute Kidney InjuryMeglumine gadoterateMagnetic Resonance ImagingNephrogenic Fibrosing DermopathyHeterocyclic CompoundsGd-DOTANephrogenic systemic fibrosisOrganometallic CompoundsHumansFemaleRenal Insufficiency ChronicGadolinium-based contrast agent-induced nephropathyMRIRoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin
researchProduct

Differentiation of benign and malignant lymph nodes in pediatric patients on ferumoxytol-enhanced PET/MRI.

2019

The composition of lymph nodes in pediatric patients is different from that in adults. Most notably, normal lymph nodes in children contain less macrophages. Therefore, previously described biodistributions of iron oxide nanoparticles in benign and malignant lymph nodes of adult patients may not apply to children. The purpose of our study was to evaluate if the iron supplement ferumoxytol improves the differentiation of benign and malignant lymph nodes in pediatric cancer patients on 18F-FDG PET/MRI. Methods: We conducted a prospective clinical trial from May 2015 to December 2018 to investigate the value of ferumoxytol nanoparticles for staging of children with cancer with 18F-FDG PET/MRI.…

Malemedicine.medical_specialtyAdolescentAnemiaMRI contrast agentMedicine (miscellaneous)030218 nuclear medicine & medical imagingLesioncancer imaging03 medical and health sciences0302 clinical medicineFluorodeoxyglucose F18lymph nodesNeoplasmsferumoxytolmedicineHumansProspective StudiesChildPharmacology Toxicology and Pharmaceutics (miscellaneous)Lymph nodeReceiver operating characteristicbusiness.industryCell Differentiationmedicine.diseasePediatric cancerMagnetic Resonance ImagingFerrosoferric Oxide3. Good healthFerumoxytolmedicine.anatomical_structurePET/MRI030220 oncology & carcinogenesisPositron-Emission TomographyNanoparticlesFemaleRadiologyLymphmedicine.symptomRadiopharmaceuticalsbusinessResearch PaperTheranostics
researchProduct

Silica-coated superparamagnetic nanoparticles as contrast agent for magnetic resonance imaging: Synthesis and physicological charaterizations

2015

Superparamagnetic iron oxide nanoparticles (SPIONs) have received a growing interest for various biomedical applications due to their interesting magnetic properties. Herein, we report a method for facile synthesis of colloidal silica-coated superparamagnetic iron oxide nanoparticles (Si-SPIONs). The polyvinyl alcohol (PVA)-SPIONs were successfully prepared and then coated with silica by the modified Stober method. The obtained Si-SPIONs are highly monodisperse with uniform morphology. Notably, comparing to uncoated SPIONs, silica coated ones show colloidal stability region at physiological pH which is applicable in biomedical applications and synthesis at the scale of grams was easily obta…

Materials sciencemedicine.diagnostic_testSuperparamagnetic iron oxide nanoparticlesMRI contrast agent[SPI.NANO] Engineering Sciences [physics]/Micro and nanotechnologies/MicroelectronicsDispersityNanotechnologyMagnetic resonance imagingSuperparamagnetic nanoparticlesPolyvinyl alcoholColloidchemistry.chemical_compoundchemistrymedicineParticle[SPI.NANO]Engineering Sciences [physics]/Micro and nanotechnologies/MicroelectronicsComputingMilieux_MISCELLANEOUS
researchProduct

Gadolinium-chelating nanogels as MR contrast agents specifically targeting tumor cells

2014

Aims and objectives Methods and materials Results Conclusion Personal information References

Molecular imaging Diagnostic procedure MR-Functional imaging MR Contrast agentsMolecular genomics and proteomicsgenetic structuresMolecular imagingMRDiagnostic procedureContrast agentsMR-Functional imaging
researchProduct

MSCT in GIST patients with hepatic metastases treated with new generation tyrosinkinase inhibitors: comparison between density and dimension

2013

Purpose Methods and Materials Results Conclusion References Personal Information

StagingOncologyGastrointestinal tractAbdomenMonoclonal antibodiesMetastasesContrast agent-intravenousOncology Abdomen Gastrointestinal tract CT Contrast agentintravenous Staging Cancer Metastases Monoclonal antibodiesSettore MED/36 - Diagnostica Per Immagini E RadioterapiaCTCancer
researchProduct

Synthetic strategy for preparation of a folate corrole DOTA heterobimetallic Cu–Gd complex as a potential bimodal contrast agent in medical imaging

2015

Abstract An efficient sequential route to synthesize heterobimetallic complexes is reported herein. A folate, Cu corrole, Gd DOTA complex that addresses the requirements of a potential contrast agent (CA) for bimodal imaging (e.g., MRI/PET) is reported. The over-expression of the folate receptor in a variety of malignant tumors, along with its limited expression in healthy tissues, makes this an attractive tumor-specific molecular target. Synthesis of a bimetallic ligand potentially targeting the folate receptor, was easily achieved in only a few steps. Interestingly, preliminary studies showed that the relaxivity of the folic heterobimetallic derivative was higher in comparison to a clinic…

StereochemistryGadoliniumMRI contrast agentOrganic Chemistrychemistry.chemical_elementLigand (biochemistry)BiochemistryCombinatorial chemistryImaging agentchemistry.chemical_compoundchemistryIn vivoFolate receptorDrug DiscoveryDOTACorroleTetrahedron Letters
researchProduct

Focal liver lesions: clinical usefulness of contrast-enhanced ultrasound in the selection of surgical patients

2009

Purpose: to evaluate the role of contrast-enhanced ultrasound (CEUS) in the characterization of focal liver lesions (FLLs) for surgical patients selection. Materials and Methods: 135 consecutive patients (71 women, 64 men) with 165 FLLs (mean size: 3.1 cm) - 89 benign (10 simple cysts, 26 hemangiomas, 29 focal nodular hyperplasia (FNH), 2 hepatocellular adenomas, 11 focal fatty sparing, 3 focal fatty areas, 5 regenerative nodules, 2 hydatid cysts, 1 abscess) and 76 malignant - 47 metastases, 26 hepatocellular carcinomas and 3 peripheral cholangiocarcinomas - underwent CEUS after the administration of SonoVue®. Two readers reviewed in consensus baseline US and CEUS scans obtained 25-30 s (ar…

contrast-enhanced ultrasound liver neoplasm ultrasonographic contrast agentSettore MED/18 - Chirurgia GeneraleSettore MED/36 - Diagnostica Per Immagini E Radioterapia
researchProduct

Imaging findings of hepatic Focal Nodular Hyperplasia (FNH) in Gadoxetic Acid vs Gadobenate Dimeglumine-enhanced MR: preliminary results

2009

focal nodular hyperplasia hepatocellular-specific contrast agent
researchProduct

Imaging findings of hepatic focal nodular hyperplasia in Gd-EOB-DTPA vs Gd-BOPTA -enhanced MR: preliminary results.

2009

focal nodular hyperplasia hepatocellular-specific contrast agent
researchProduct

Regression of benign hepatic lesions associated with exogenous estrogens withdrawal

2014

Learning objectives Background Findings and procedure details Conclusion Personal information References

genetic structuresLivereducationAbdomenOutcomesMROutcomes Contrast agent-intravenous MR Liver AbdomenContrast agent-intravenous
researchProduct